4911.TWO
Get informed when a big investor buys or sells
+ Follow| Market cap | $1.93 Billion |
|---|---|
| Enterprise Value | $1.79 Billion |
| Dividend Yield | $1.17 (4.16%) |
| Earnings per Share | $2.18 |
| Beta | -0.65 |
| Outstanding Shares | 74,322,353 |
| P/E Ratio | 20.9 |
|---|---|
| PEG | -26.15 |
| Price to Sales | 14.0 |
| Price to Book Ratio | 2.55 |
| Enterprise Value to Revenue | 8.29 |
| Enterprise Value to EBIT | 21.36 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the innovation and commercialization of advanced botanical extraction technologies and the products derived from them. Its diverse portfolio ...